1 asset in Meningeal Melanocytoma
Therapeutic assets addressing Meningeal Melanocytoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nivolumab Meningeal Melanocytoma | M.D. Anderson Cancer Center | P1 | CC (43) |